Franchise opportunities compared

    MedXwaste vs MN Filing 35519-202603-08

    Reviewed figures from each brand's Franchise Disclosure Document (FDD), side by side. Each figure carries its FDD year and page. This is not a ranking or recommendation, and the two FDDs may cover different years and location groups.

    Before you compare

    • Both sets of figures come from 2026 FDDs.
    • Only MN Filing 35519-202603-08 has reviewed Item 19 figures here.
    DisclosureMedXwasteMFMN Filing 35519-202603-08
    Financial commitment
    Estimated initial investment (Item 7)
    $101,535 – $141,985
    TOTAL
    2026 FDD · Item 7 · PDF p. 17
    $182,350 – $226,200
    Total initial investment range
    2026 FDD · Item 7 · PDF p. 1
    Standard initial franchise fee (Item 5)
    $50,000
    2026 FDD · Item 5 · PDF p. 11
    $74,500
    2026 FDD · Item 5 · PDF p. 8
    Royalty (Item 6)
    Greater of $650 or 8% of gross sales after 90 business days
    Royalty Fee
    2026 FDD · Item 6 · PDF p. 12
    10%
    Royalty Fee, Year 1: 10% of Gross Sales
    2026 FDD · Item 6 · PDF p. 9
    Brand / advertising fund (Item 6)
    Not available
    No reviewed brand or advertising fund fee
    0.5%
    Marketing Fund: currently 0.5% of Gross Sales — 0.5%
    2026 FDD · Item 6 · PDF p. 9
    System scale & health
    Total outlets (Item 20)
    11
    Outlets at end of 2025
    2026 FDD · Item 20 · PDF p. 41
    26
    Outlets at end of 2025
    2026 FDD · Item 20 · PDF p. 33
    Net outlet change (Item 20)
    +5
    Calculated: 6 at end of 2023 → 11 at end of 2025
    +0
    Calculated: 26 at end of 2023 → 26 at end of 2025
    Outlet exits (Item 20)
    Not available
    No complete exit records for a year
    Not available
    No complete exit records for a year
    Franchising since (Item 1)
    2019
    2026 FDD · Item 1 · PDF p. 9
    Not available
    Not in reviewed records
    Franchisor founded (Item 1)
    2019
    2026 FDD · Item 1 · PDF p. 9
    Not available
    Not in reviewed records
    Performance (Item 19)
    Financial performance (Item 19), by location group
    Not disclosed — no Item 19 financial performance representation
    Locations counted not stated in the reviewed record — Franchised RENUE businesses opened 2001–2003
    $15
    other Businesses opened 2001-2003 · 2026 FDD · Item 19 · PDF p. 30
    Locations counted not stated in the reviewed record — Franchised RENUE businesses opened 2004-2007
    $14
    other Businesses opened 2004-2007 · 2026 FDD · Item 19 · PDF p. 30
    Locations counted not stated in the reviewed record — Franchised RENUE businesses opened 2008-2014
    $14
    other Businesses opened 2008-2014 · 2026 FDD · Item 19 · PDF p. 30
    +18 more groups in the full report

    Item 19 groups are shown separately and never combined. Revenue or sales figures are not profit. Net outlet change and turnover are Franopolis calculations from the disclosed counts; turnover is a count-based rate, not a measure of owner earnings.

    MedXwaste vs MN Filing 35519-202603-08: common questions

    Which costs less to open, MedXwaste or MN Filing 35519-202603-08?
    MedXwaste: $101,535 – $141,985 (2026 FDD · Item 7 · PDF p. 17); MN Filing 35519-202603-08: $182,350 – $226,200 (2026 FDD · Item 7 · PDF p. 1). These are each franchisor's Item 7 estimated initial investment. The low end of the disclosed estimate is lower for MedXwaste. Estimates are not quotes, and the FDD years may differ.
    How do MedXwaste and MN Filing 35519-202603-08 royalties compare?
    MedXwaste: Greater of $650 or 8% of gross sales after 90 business days (2026 FDD · Item 6 · PDF p. 12); MN Filing 35519-202603-08: 10% (2026 FDD · Item 6 · PDF p. 9). Royalties as disclosed in Item 6; other recurring fees are listed separately.
    Which has more locations, MedXwaste or MN Filing 35519-202603-08?
    MedXwaste: 11 (2026 FDD · Item 20 · PDF p. 41); MN Filing 35519-202603-08: 26 (2026 FDD · Item 20 · PDF p. 33). Total outlets from Item 20. Outlet counts do not indicate territory availability or franchisee results.
    Do MedXwaste and MN Filing 35519-202603-08 disclose financial performance (Item 19)?
    MedXwaste makes no Item 19 financial performance representation; MN Filing 35519-202603-08 has reviewed Item 19 figures for 21 location groups. Different location groups are not directly comparable, and revenue is not profit.

    Answers restate the reviewed figures above. Not a ranking or recommendation.

    How Franopolis reviews FDD figures